Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 901,492 | 605,732 | 305,980 | 956,978 | 726,406 |
| Depreciation Amortization | 549,758 | 362,744 | 187,083 | 745,443 | 550,166 |
| Income taxes - deferred | -53,713 | -28,643 | -3,318 | -39,354 | -17,767 |
| Accounts receivable | -175,643 | -193,093 | -561,281 | 172,361 | 118,148 |
| Accounts payable and accrued liabilities | -43,414 | -38,998 | -14,162 | 26,890 | -33,837 |
| Other Working Capital | -91,157 | -363,271 | -640,146 | 194,535 | 183,822 |
| Other Operating Activity | 387,088 | 319,539 | 591,008 | 2,178 | 46,888 |
| Operating Cash Flow | $1,474,411 | $664,010 | $-134,836 | $2,059,031 | $1,573,826 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,011 | 844 | -2,984 | 100,438 | 57,302 |
| PPE Investments | -366,849 | -232,961 | -113,975 | -537,375 | -409,011 |
| Net Acquisitions | -161,210 | -157,783 | -105,163 | -26,394 | 16,917 |
| Purchase Of Investment | -4,497 | 6,382 | -460 | -313,382 | -276,006 |
| Sale Of Investment | 4,558 | N/A | 4,547 | N/A | 3,930 |
| Other Investing Activity | 6,554 | 6,554 | 2,829 | 4,913 | 3,364 |
| Investing Cash Flow | $-523,455 | $-376,964 | $-215,206 | $-771,800 | $-603,504 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,623,634 | 3,275,533 | 1,290,255 | 2,468,341 | 2,468,335 |
| Debt Repayment | -5,437,907 | -2,661,145 | -554,544 | -3,020,956 | -2,992,248 |
| Common Stock Issued | 15,204 | 7,421 | 4,143 | 16,900 | -41,155 |
| Common Stock Repurchased | -1,020,550 | -612,614 | -250,961 | -272,219 | 0 |
| Other Financing Activity | -432,215 | -253,171 | -169,574 | -362,561 | -202,181 |
| Financing Cash Flow | $-251,834 | $-243,976 | $319,319 | $-1,170,495 | $-767,249 |
| Exchange Rate Effect | -5,112 | -4,458 | -3,130 | 8,909 | 3,063 |
| Beginning Cash Position | 464,634 | 464,634 | 464,634 | 338,989 | 338,989 |
| End Cash Position | 1,158,644 | 503,246 | 430,781 | 464,634 | 545,125 |
| Net Cash Flow | $694,010 | $38,612 | $-33,853 | $125,645 | $206,136 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,474,411 | 664,010 | -134,836 | 2,059,031 | 1,573,826 |
| Capital Expenditure | -384,786 | -245,740 | -121,015 | -567,985 | -409,011 |
| Free Cash Flow | 1,089,625 | 418,270 | -255,851 | 1,491,046 | 1,164,815 |